India presents its first homegrown H5N1 vaccine for chickens


The vaccine’s reported price is 1–2 Indian rupees per dose. Use on poultry farms depends on regulatory approval and a government decision on whether to allow H5 vaccination.
India’s agriculture minister, Shivraj Singh Chouhan, presented the country’s first homegrown H5N1 vaccine for chickens in Bhopal on 20 November 2026. Scientists at the ICAR–National Institute of High Security Animal Diseases, a government research institute in the city, developed it. The Indian Express put the price at 1–2 Indian rupees per dose.
H5N1 is a severe form of bird flu that can kill large numbers of chickens. Outbreaks can also force farmers to destroy birds and incur financial losses. India’s Ministry of Agriculture and Farmers Welfare says the country has recorded more than 500 outbreaks involving H5N1 and H5N8, another form of bird flu, since its first confirmed severe H5N1 outbreak in poultry in 2006.
The vaccine uses an inactivated virus, one that can no longer reproduce. It targets a genetic group of H5N1 called clade 2.3.2.1a, which the institute says accounts for most H5N1 outbreaks in Indian poultry.
The institute says the vaccine protected chickens for up to 6 months in experimental trials and stopped transmission to chickens housed with vaccinated birds. The trials used egg-laying and growing chickens that were free of specified disease-causing organisms, leaving open how well the vaccine would work on commercial farms. The institute says manufacturers could adopt the technology, particularly for use in egg-laying and breeding chickens.

“The indigenous vaccine will strengthen bird flu control in India and protect chickens,” Chouhan said. India’s 2024 Poultry Disease Action Plan said vaccination against the H5 and H7 groups of bird flu viruses had not been allowed.
Gandhi News says current outbreak controls include killing birds within 1 km of an infected farm, closing nearby shops within 10 km and waiting 90 days before restocking. For the vaccine to reach farms, it needs regulatory approval, a manufacturer and a government decision allowing H5 vaccination. None has been announced. The ministry’s release did not specify when doses would reach farms.
UN Women and its partners say more than 193 service points for survivors of gender-based violence have also closed, while millions of women and girls face reduced access to essential services.
2 min

The team says the shell around IRAS 06530-0213 is the first direct evidence of a final thermal pulse in a star already entering its last transition.
3 min

The team proposes that waves steepen into shocks that launch the jets, offering a way to investigate how energy reaches the Sun’s much hotter outer atmosphere.
2 min